Alnylam Pharmaceuticals
ALNY
#643
Rank
NZ$67.60 B
Marketcap
NZ$506.32
Share price
-1.02%
Change (1 day)
4.57%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company